Editorial: trials underway for topical botulinum toxin
Rosalind Hill considers the ongoing trials for topical botulinum toxin, and the bold claims of some over-the-counter skincare products
Read MorePRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
